JUDITH STRAPP: Open Payments
NPI 1770693228 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 37 payments from 17 companies in 2025. Trend: 2023 $425 · 2024 $1,278 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 3 | $162 |
| GlaxoSmithKline, LLC. | 6 | $148 |
| Phathom Pharmaceuticals, Inc. | 2 | $144 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Lilly USA, LLC | 4 | $74 |
| Inspire Medical Systems, Inc. | 3 | $66 |
| Exact Sciences Corporation | 3 | $63 |
| Novo Nordisk Inc | 2 | $44 |
| Seqirus USA Inc | 1 | $26 |
| PFIZER INC. | 1 | $24 |
Products named: ZORYVE, TRELEGY ELLIPTA, VOQUEZNA, FARXIGA, INSPIRE, Cologuard Collection Kit, MOUNJARO, Ozempic.
Industry payments across TX — which companies pay providers there.
